Buck Institute for Research on Aging

Research Institutions Continue to Adopt and Implement Cayuse

Retrieved on: 
Wednesday, November 8, 2023
Biomedical Research, Ageing, Buck Institute for Research on Aging, University of Montana, Ethics, Research, Era, Connect, Notifiable disease, University, Western Governors University, Management, Cayuse

Portland, Oregon, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Cayuse, the leader in electronic research administration (eRA) software, today announced additional successful implementations of Cayuse eRA solutions among several notable research institutions.

Key Points: 
  • Portland, Oregon, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Cayuse, the leader in electronic research administration (eRA) software, today announced additional successful implementations of Cayuse eRA solutions among several notable research institutions.
  • Following another successful Connect by Cayuse virtual conference this fall, Cayuse leadership is proud to welcome the newest adopters to the community of Cayuse users:
    AAPlasma LLC, an innovative engineering organization focused on the research and development of advanced oxidation processes for industrial applications, recently went live with Cayuse’s funding and effort management solutions, Fund Manager and Project Effort .
  • Buck Institute, an independent biomedical research institute that specializing in aging and age-related disease, completed the implementation of Cayuse Sponsored Projects and Proposals (S2S) .
  • Western Governors University, a national, competency-based, online university providing career-relevant, post-secondary education for working professionals, launched Cayuse Sponsored Projects this August.

Trailblazing the Future of Healthy Aging Science: Timeline® Hosts the First Global Urolithin A Summit With a Full-day Virtual Experience

Retrieved on: 
Friday, November 3, 2023
Other Health, Other Communications, Diabetes, Health, General Health, Oncology, Communications, Other Science, Research, Fitness & Nutrition, Science, Ageing, National University of Singapore, Buck Institute for Research on Aging, Doctor of Philosophy, Princeton University, University of Rhode Island, Urolithin A, National university, University, University of Oslo, Longevity, Nursing, Timeline, MD

On November 7th, the first global Urolithin A Scientific Summit, brought to the world stage by Timeline , is set to present paradigm-shifting research in the field of longevity.

Key Points: 
  • On November 7th, the first global Urolithin A Scientific Summit, brought to the world stage by Timeline , is set to present paradigm-shifting research in the field of longevity.
  • Led by experts in the scientific community, the virtual summit, open to the general public, practitioners, and scientists, will highlight the latest research in aging, particularly focusing on Urolithin A—a breakthrough postbiotic natural molecule with a meaningful impact on health.
  • Urolithin A stands at the forefront of healthy aging with its unique potential to target several of the most important hallmarks of aging.
  • “Timeline has always been at the cutting edge and this event marks a significant milestone in our journey of raising the bar in longevity, nutrition and skin health science.”

Famed Scientist Lee Hood Will Co-Direct the Center for Phenomic Health at the Buck Institute

Retrieved on: 
Wednesday, September 27, 2023
Kyoto Prize in Basic Sciences, DNA, Kyoto Prize, National academy, Buck Institute for Research on Aging, Partnership, Systems biology, National Academy of Engineering, Ageing, Buck, National Medal, Research, Doctor of Philosophy, Institute for Systems Biology, Science, National Academy of Medicine, Human, Blood, Saliva, Biology, Information Innovation Office, National Medal of Science, Health, Human Genome Project, Distinguishing, Health information management, Professors in the United States, Disease, Pharmaceutical industry, MD, Medicine

NOVATO, Calif., Sept. 27, 2023 /PRNewswire/ -- The Buck Institute for Research on Aging and Phenome Health are joining forces in the quest to understand the biology of aging. Phenome Health, a Seattle-based nonprofit research organization led by CEO Lee Hood, MD, PhD, uses a data-driven approach to health and disease that integrates diverse types of biological big data. The new Center for Phenomic Health at the Buck will be co-led by Dr. Hood, who joins the Buck as Chief Innovation Officer and Distinguished Professor, and Eric Verdin, MD, Buck President and CEO.

Key Points: 
  • The new Center for Phenomic Health at the Buck will be co-led by Dr.
  • Hood, who joins the Buck as Chief Innovation Officer and Distinguished Professor, and Eric Verdin, MD, Buck President and CEO.
  • Hood is a world-renowned scientist whose technology (automated DNA sequencing) paved the way for the Human Genome Project.
  • The opportunity to form a Center with Lee Hood and his Phenome Health team will be transformational for the Buck," said Dr. Verdin.

Impetus Grants Secures $10 million Commitment from Hevolution Foundation and Rosenkranz Foundation to Fund Aging Science

Retrieved on: 
Tuesday, July 25, 2023
Health, Health Technology, Other Health, Clinical Trials, Research, Science, Learning, Buck Institute for Research on Aging, Grant, Ageing, Biomarker, Buck, Entrepreneurship, Pharmaceutical industry, Impetus

Impetus Grants, a nonprofit foundation dedicated to funding aging-related research that might otherwise be overlooked by traditional funding sources, announces a new round of matching funding.

Key Points: 
  • Impetus Grants, a nonprofit foundation dedicated to funding aging-related research that might otherwise be overlooked by traditional funding sources, announces a new round of matching funding.
  • Hevolution Foundation , a global non-profit organization that provides grants and early-stage investments to incentivize research and entrepreneurship in healthspan science, is contributing $5 million to Impetus Grants.
  • Since its founding in 2021, Impetus Grants has deployed more than $24 million into aging-related scientific research, supporting a number of aging-related clinical trials, biomarkers, novel tools and model organisms.
  • With this new funding from Hevolution Foundation and Rosenkranz Foundation, Impetus will expand its efforts to fund high-risk, high-reward science in aging.

Clinical Trial Affirms (R)-1,3-Butanediol Effectively Induces and Sustains Ketosis

Retrieved on: 
Wednesday, June 28, 2023
Biotechnology, General Health, Health, Vitamins, Supplements, Food, Beverage, Fitness & Nutrition, Clinical Trials, Retail, Human, GRAS, Buck Institute for Research on Aging, Diet, Drink, Somnolence, BHB, Glucose, Clinical trial, Multimedia, Ketosis, Pasta â Paolina, Ageing, Doctor of Philosophy, Gel, Research, Fasting, Ketone, Dietary supplement, Vaccine, Physiology

Today, Geno announced the results of a new clinical trial exploring the effects of its exogenous ketone, Avela, when consumed in beverage form.

Key Points: 
  • Today, Geno announced the results of a new clinical trial exploring the effects of its exogenous ketone, Avela, when consumed in beverage form.
  • View the full release here: https://www.businesswire.com/news/home/20230628271053/en/
    The study results provide further support that Avela is effective at raising BHB levels and generating on-demand ketosis within 30 minutes of ingestion.
  • The ingredient induced and maintained ketosis for up to five hours when administered orally in a three-dose process.
  • The clinical trial demonstrates the value of Avela as an effective method for raising BHB levels in humans to achieve nutritional ketosis.

67-Year-Old Founder of Ponce De Leon Health Achieves ‘Longevity Escape Velocity’ with Rejuvant

Retrieved on: 
Tuesday, March 28, 2023
Exercise, Tissue, DNA, Hair, Buck Institute for Research on Aging, Diet, Sleep, Ageing, Longevity, Woman, Vitamin A, Infection, Cell, Life expectancy, Tablet, DNaM, Conditional sentence, Vitamin D, DNA methylation, Health, Research, B, Glass, Wine, Dietary supplement, Electric battery

While this may seem difficult to achieve through rigorous exercise and a strict diet, Tom Weldon , the founder and CEO of Ponce de Leon Health , has accomplished longevity escape velocity with one supplement, his own Rejuvant .

Key Points: 
  • While this may seem difficult to achieve through rigorous exercise and a strict diet, Tom Weldon , the founder and CEO of Ponce de Leon Health , has accomplished longevity escape velocity with one supplement, his own Rejuvant .
  • Weldon reached longevity escape velocity after taking Rejuvant for just two and a half years, meaning that the reversal of his biological age began exceeding the increase of his chronologic age.
  • Tom Weldon, founder and CEO of Ponce de Leon Health, reached longevity escape velocity after taking Rejuvant for just two and a half years, meaning that the reversal of his biological age began exceeding the increase of his chronologic age.
  • Tom Weldon developed Rejuvant to help cells maintain a healthy metabolism, while maintaining a youthful epigenetic state.

Nautilus Biotechnology Announces “First Access Challenge” Winners

Retrieved on: 
Tuesday, March 7, 2023
PRISM, Brigham Young University, IRI, AKI, Buck Institute for Research on Aging, Organoid, Biomarker, Glioma, US, Therapy, Arginine, Postdoctoral researcher, Pathology, Conference, Research, Access, Creativity, University, Acute kidney injury, Pulmonary fibrosis, Human Proteome Organization, Systems biology, Travel, Associate, Ageing, Proteome, Proteomics, Pharmaceutical industry, Medical imaging, Nautilus

SEATTLE, March 07, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, announced the selection of three research proposals submitted to the First Access Challenge, a competition for furthering high-impact work in proteomics.

Key Points: 
  • SEATTLE, March 07, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, announced the selection of three research proposals submitted to the First Access Challenge, a competition for furthering high-impact work in proteomics.
  • The winning projects were also revealed at the US HUPO (Human Proteome Organization) 2023 Conference in Chicago, IL.
  • “We congratulate each of the winners and look forward to the biomedical and life sciences advances that our collaborations may enable," said Parag Mallick, Ph.D., co-founder and Chief Scientist of Nautilus.
  • “The response from researchers across the globe to this First Access Challenge has been incredibly rewarding.

Fountain Life Appoints Mark Hyman, M.D., to Medical Advisory Board

Retrieved on: 
Monday, March 6, 2023
Life, Mark Hyman (doctor), Functional medicine, The Wall Street Journal, Ageing, Buck Institute for Research on Aging, CBS, Education, Pharmacy, Stanford University, The View, CNN, Doctor, Health, Food, Television, Longevity, Senior advisor, Policy, Functional, Secrecy, Research, Harvard University, Pharmaceutical industry, Management, Amazon, The New York Times

NAPLES, Fla., March 6, 2023 /PRNewswire/ -- Fountain Life, a preventative health and longevity company committed to transforming global healthcare from reactive to proactive, today announced the appointment of Mark Hyman, M.D. to the company's Medical Advisory Board.

Key Points: 
  • Dr. Hyman brings expertise in healthcare and wellness advocacy, leadership, and education to the Fountain Life Medical Advisory Board
    NAPLES, Fla., March 6, 2023 /PRNewswire/ -- Fountain Life, a preventative health and longevity company committed to transforming global healthcare from reactive to proactive, today announced the appointment of Mark Hyman, M.D.
  • "We are honored to welcome Dr. Hyman to our Medical Advisory Board," said Bill Kapp, M.D., Fountain Life CEO and co-founder.
  • "I am thrilled to join Fountain Life's esteemed Medical Advisory Board and contribute to making their innovative healthcare offerings available to more members across the U.S. and globally."
  • Hyman joins Eric Verdin, M.D., president and chief executive officer of the Buck Institute for Research on Aging, and Daniel Kraft, M.D., Stanford and Harvard-trained physician-scientist, inventor, entrepreneur on the Fountain Life Medical Advisory Board.

PBLWorks Receives a $2.5 million Grant from the One8 Foundation

Retrieved on: 
Monday, February 13, 2023
Organization, OER, K-12, PBL, Learning, Black and Brown!, Buck Institute for Research on Aging, Mathematics, Kentucky Department of Fish and Wildlife Resources, KDE, Student, Education, Project-based learning, Gold standard, STEM, Tutoring

NOVATO, Calif., Feb. 13, 2023 /PRNewswire-PRWeb/ -- The Buck Institute for Education (dba PBLWorks), a national provider of professional development for high-quality Project Based Learning (PBL), today announces that it has received $2.5 million from the One8 Foundation. The One8 Foundation is supporting the development of supplemental Open Educational Resource (OER) Project Based Learning units for mathematics in grades 6–8. The project will focus on building and testing the PBL units in collaboration with teachers and students in Massachusetts. Once fully developed, these supplemental PBL mathematics units will be open educational resources available to teachers throughout the United States.

Key Points: 
  • NOVATO, Calif., Feb. 13, 2023 /PRNewswire-PRWeb/ -- The Buck Institute for Education (dba PBLWorks), a national provider of professional development for high-quality Project Based Learning (PBL), today announces that it has received $2.5 million from the One8 Foundation.
  • The One8 Foundation is supporting the development of supplemental Open Educational Resource (OER) Project Based Learning units for mathematics in grades 6–8.
  • The One8 Foundation partners with organizations that provide effective applied learning and STEM education programs.
  • "One8 is giving us an opportunity to develop equity-focused mathematics materials that can support teachers in implementing Gold Standard PBL.

15th Annual Biotech Showcase™ Brings Together One Of The Largest, Most Informative In-Person Biotech Investment Conferences

Retrieved on: 
Wednesday, January 18, 2023
Technology, Research, Other Technology, Biotechnology, Health, Pharmaceutical, General Health, Other Science, Science, Equality, U.S. Department of Defense Strategy for Operating in Cyberspace, COVID-19, CNS, Buck Institute for Research on Aging, Assistant professor, Reproduction, United States Department of Veterans Affairs, Dawn, Inflation, Drug discovery, Business development, Innovation, IRA, Times Are Changing (album), Nightclub, Pharmaceutical industry, Bank, Veteran

In its 15th year, Biotech Showcase™ , co-produced by Demy-Colton and EBD Group , welcomed more than 3,200 attendees, more than 1,100 investors, and more than 400 presenting companies.

Key Points: 
  • In its 15th year, Biotech Showcase™ , co-produced by Demy-Colton and EBD Group , welcomed more than 3,200 attendees, more than 1,100 investors, and more than 400 presenting companies.
  • The event allowed attendees to explore impactful trends, engage industry experts, discover innovative companies, and meet motivated investors.
  • In an annual event meant to drive the future of drug discovery and development, this year’s participants engaged in 24 program sessions and panels, which included more than 115 speakers.
  • The 2023 program featured insights from top investors and biopharma executives across a broad spectrum of expertise.